Literature DB >> 21041058

Development and psychometric properties of a self report measure to assess clinicians' practices in self management support for patients with long term conditions.

Joanna Kosmala-Anderson1, Louise M Wallace, Andy Turner, Fred Barwell.   

Abstract

OBJECTIVE: This paper presents a process of developing practices in self management support (PSMS) - a measure assessing clinicians' self reported use of self management support practices in clinical consultations for patients with long term conditions (LTCs).
METHODS: The development process comprised the following steps: literature review to define what skills clinicians need to effectively support patients to self manage, review of existing measures of SMS practices, construction of an initial pool of items, E Delphi study pilot survey to select items for final measure, data collection to confirm the factor structure and internal consistency of the final measure.
RESULTS: The PSMS comprises three subscales: Clinical SMS (14 items), Patient Centeredness (4 items) and Organizational SMS (7 items). All subscales have very good internal reliability (Cronbach α: 0.94, 0.78 and 0.85; all item-total correlations above 0.50). CONCLUSIONS AND PRACTICE IMPLICATIONS: We believe PSMS measure is suitable for both research and programme evaluation in UK clinical settings. To complete the process of measure development we are now planning to conduct further analyses to establish the validity of PSMS measure in UK and non UK healthcare settings and test the validity of PSMS measure on a wider range of other LTC groups.
Copyright © 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 21041058     DOI: 10.1016/j.pec.2010.10.007

Source DB:  PubMed          Journal:  Patient Educ Couns        ISSN: 0738-3991


  1 in total

1.  Does the professional and working context of United Kingdom clinicians predict if they use practices to support patients with long term conditions to self manage?

Authors:  Joanna Kosmala-Anderson; Louise M Wallace; Andrew Turner
Journal:  Arch Med Sci       Date:  2010-10-26       Impact factor: 3.318

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.